Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative

Journal of the American College of Surgeons

Volumn 221, Issue 2, 2015, Pages 291-299

  Gholami, Sepideh ^a   Janson, Lucas ^b   Worhunsky, David J ^a   Tran, Thuy B ^a   Squires, Malcolm Hart ^c   Jin, Linda X ^d   Spolverato, Gaya ^e   Votanopoulos, Konstantinos I ^f   Schmidt, Carl ^g   Weber, Sharon M ^h   Bloomston, Mark ^g   Cho, Clifford S ^h   Levine, Edward A ^f   Fields, Ryan C ^d   Pawlik, Timothy M ^e   Maithel, Shishir K ^c   Efron, Bradley ^b   Norton, Jeffrey A ^a   Poultsides, George A ^a  

^a STANFORD CANCER INSTITUTE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d BARNES JEWISH HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; GASTRECTOMY; HOSPITAL READMISSION; HUMAN; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; SURVIVAL TIME; ADENOCARCINOMA; CANCER STAGING; CLINICAL TRIAL; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84937687368     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.04.024     Document Type: Article

References (24)

1. A. Jemal, F. Bray, M.M. Center, and et al. Global Cancer Statistics CA Cancer J Clin 61 2011 69 90
2. K. Maruyama, K. Okabayashi, and T. Kinoshita Progress in gastric cancer surgery in Japan and its limits of radicality World J Surg 11 1987 418 425
3. A. Cuschieri, P. Fayers, J. Fielding, and et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 347 1996 995 999
4. A. Cuschieri, S. Weeden, J. Fielding, and et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 1999 1522 1530
5. J.J. Bonenkamp, J. Hermans, M. Sasako, and et al. Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908 914
6. H.H. Hartgrink, C.J. van de Velde, H. Putter, and et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2004 2069 2077
7. M. Degiuli, M. Sasako, and A. Ponti Italian Gastric Cancer Study Group: Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 vs D2 resection for gastric cancer Br J Surg 97 2010 643 649
8. K. Maruyama, M. Sasako, T. Kinoshita, and et al. Pancreas-preserving total gastrectomy for proximal gastric cancer World J Surg 19 1995 532 536
9. M. Sasako, T. Sano, S. Yamamoto, and et al. Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 2008 453 462
10. C.W. Wu, C.A. Hsiung, S.S. Lo, and et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial Lancet Oncol 7 2006 309 315
11. I. Songun, H. Putter, E.M. Kranenbarg, and et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial Lancet Oncol 11 2010 439 449
12. A.M. Bouvier, O. Haas, F. Piard, and et al. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study Cancer 94 2002 2862 2866
13. D.D. Smith, R.R. Schwarz, and R.E. Schwarz Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database J Clin Oncol 23 2005 7114 7124
14. M.S. Karpeh, L. Leon, D. Klimstra, and et al. Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients Ann Surg 232 2000 362 371
15. H.K. Lee, H.K. Yang, W.H. Kim, and et al. Influence of the number of lymph nodes examined on staging of gastric cancer Br J Surg 88 2001 1408 1412
16. J.R. Siewert, K. Bottcher, H.J. Stein, and et al. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study Ann Surg 228 1998 449 461
17. L.H. Sobin, and I.D. Fleming TNM Classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 1997 1803 1804
18. S.B. Edge, D.R. Byrd, C.C. Compton, and et al. AJCC Cancer Staging Manual 7th ed. 2009 Springer-Verlag New York 117 126
19. P.A. Clavien, J. Barkun, M.L. de Oliveira, and et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
20. B. Efron Two modeling strategies for empirical Bayes estimation Stat Sci 29 2014 285 301
21. M.W. Kattan, M.S. Karpeh, M. Mazumdar, and et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma J Clin Oncol 21 2003 3647 3650
22. B. Schmidt, K.K. Chang, U.N. Maduekwe, and et al. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging Ann Surg Oncol 20 2013 2991 2999
23. T.E. Le Voyer, E.R. Sigurdson, A.L. Hanlon, and et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 J Clin Oncol 21 2003 2912 2919
24. C.G. Peyre, J.A. Hagen, S.R. DeMeester, and et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 2008 549 556